Envoy Medical Inc. Secures Two New U.S. Patents, Enhancing Its Portfolio in Hearing Health Innovations

Reuters
2025/07/08
<a href="https://laohu8.com/S/COCH">Envoy Medical Inc.</a> Secures Two New U.S. Patents, Enhancing Its Portfolio in Hearing Health Innovations

Envoy Medical Inc. has announced the issuance of two new patents, enhancing its intellectual property holdings in the United States. The U.S. Patent & Trademark Office granted U.S. Patent No. 12,318,607, titled "Implantable Cochlear System with Integrated Components and Lead Characterization," and U.S. Patent No. 12,318,613, titled "Implantable Cochlear Implant System with Integrated Signal Analysis Functionality," both on June 3, 2025. These patents cover methods related to compensating for variability in a middle ear sensor and using external devices for signal analysis in fully implantable cochlear systems.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 258045) on July 08, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10